Zuellig Pharma is one of the largest healthcare services groups in Asia and their purpose is to make healthcare more accessible. They provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started almost a hundred years ago and has grown to become a US$13 billion business covering 13 markets with over 10,000 employees. Their people serve over 350,000 medical facilities and work with over 1,000 clients, including the top 20 pharmaceutical companies in the world.
More recently, they launched their Zuellig Health Solutions Innovation Centre to develop new services and address some pressing healthcare needs in Asia. Since then, their teams have been focused on creating data, digital and disease management solutions, supporting patients with chronic conditions and helping payors manage healthcare costs.
PURPOSE
As one of the largest healthcare services groups in Asia, they will continue to grow by being true to their mission of making healthcare more accessible. Since 2015, they have been on a journey of transformation to bring new solutions to the industry, building on their capabilities as a specialist healthcare distributor.
Their focus in Asia makes them familiar with its diverse culture and needs. They tap into their strong local network of healthcare facilities, professionals and regulators for reliable market intelligence to stay on top of the evolving healthcare environment.
Their reputation is built on their commitment to compliance and quality. They own and operate some of the most advanced cold chain facilities that safely manage temperature-sensitive medicines. Their team are proud of their values and how they operate with integrity.
They provide progressive solutions to meet changing healthcare needs. The Zuellig Health Solutions innovation centre pioneers new ways to address healthcare challenges including data analytics, commercial services, and patient and payor services.
